Products
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceHiro for Analytics
Synapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
2026 R&D Benchmark Report
Glossary
Free tools
NEWWebinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
No credit card required
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Explore the SPS drug pipeline: GAD65 autoantibodies, GABA pharmacology, rituximab, IVIG, and emerging immunotherapy approaches for this ultra-rare CNS disorder.
Article | Report EWoD display technology patent landscape 2026: key assignees, driving waveform innovations, color architectures, and strategic IP gaps across 30+ records.
Article | Report How heterogeneous integration of III-V compound semiconductors on silicon enables next-generation RF front-end modules for 5G and beyond. Patent analysis & key players.
Article | Report A 2026 patent and literature landscape of cryogenic propellant storage: LH2, LOX, LNG systems, TVS, MLI insulation, and Mars ISRU — key trends and assignees mapped.
Article | Report Explore the CF drug pipeline beyond CFTR modulators: SPM therapy, ENaC inhibition, mRNA delivery, gene therapy, and mutation-agnostic approaches for the 10–19% ineligible population.
Article | Report How to reduce plasma-induced damage during reactive ion etching of low-k dielectric layers in advanced logic nodes — mechanisms, process strategies, and ALE.
Article | Report Explore the 2026 cellulose acetate membrane technology landscape: nanocomposite filtration, hemodialysis biocompatibility, antimicrobial packaging, and IP strategy.
Article | Report How to reduce plasma-induced damage during reactive ion etching of low-k dielectrics in sub-7 nm logic nodes — chemistry, pulsed RF, ALE, and passivation strategies.
Article | Report RNA silencing, TTR stabilizers, CRISPR editing, and monoclonal antibodies are reshaping the ATTR amyloidosis pipeline beyond patisiran. Explore the IP landscape.
Article | Report VRFB electrolyte technology landscape 2026: concentration enhancement, additive science, hybrid redox couples, and non-aqueous systems mapped across 40 years of patents.
Article | Report How interface trap density at gate dielectric boundaries drives threshold voltage instability in GaN power HEMTs — mechanisms, measurement, and mitigation strategies.
Article | Report How interface trap density at gate dielectric boundaries drives threshold voltage instability in GaN power HEMTs — mechanisms, measurements, and mitigation strategies.
Article | Report Gene therapy, cardiac regeneration, and structural defect correction approaches in the CHD drug pipeline — AAV vectors, RNA therapeutics, organoids, and more.
Article | Report Patent landscape analysis of transparent conductive electrode (TCE) technology in 2026: metal mesh, ITO alternatives, carbon-based, and stretchable architectures mapped across 5 material families.
Article | Report mTOR inhibitors, AAV gene therapy, ganaxolone, and ASO strategies shaping the TSC drug pipeline. A patent-intelligence analysis by PatSnap Insights.